位置:首页 > 蛋白库 > MYPC3_MOUSE
MYPC3_MOUSE
ID   MYPC3_MOUSE             Reviewed;        1270 AA.
AC   O70468; O88997;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1998, sequence version 1.
DT   03-AUG-2022, entry version 144.
DE   RecName: Full=Myosin-binding protein C, cardiac-type;
DE            Short=Cardiac MyBP-C;
DE   AltName: Full=C-protein, cardiac muscle isoform;
GN   Name=Mybpc3;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=FVB/NJ; TISSUE=Heart muscle;
RX   PubMed=10532952; DOI=10.1161/01.res.85.9.841;
RA   Yang Q., Sanbe A., Osinska H., Hewett T.E., Klevitsky R., Robbins J.;
RT   "In vivo modeling of myosin binding protein C familial hypertrophic
RT   cardiomyopathy.";
RL   Circ. Res. 85:841-847(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Heart muscle;
RA   McDonald K.S., Hollander M.S., Moss R.L.;
RT   "Sequence of the cardiac isoform of murine myosin binding protein-C (MyBP-
RT   C) cDNA.";
RL   Submitted (OCT-1998) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   ACETYLATION AT MET-1, AND PHOSPHORYLATION AT SER-273; SER-282 AND SER-302.
RX   PubMed=19541641; DOI=10.1073/pnas.0813369106;
RA   Ge Y., Rybakova I.N., Xu Q., Moss R.L.;
RT   "Top-down high-resolution mass spectrometry of cardiac myosin binding
RT   protein C revealed that truncation alters protein phosphorylation state.";
RL   Proc. Natl. Acad. Sci. U.S.A. 106:12658-12663(2009).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-47; SER-72; SER-307; SER-423;
RP   SER-455 AND SER-546, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Heart, and Lung;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [5]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT ARG-1237, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain;
RX   PubMed=24129315; DOI=10.1074/mcp.o113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V., Aguiar M.,
RA   Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C., Vemulapalli V.,
RA   Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
CC   -!- FUNCTION: Thick filament-associated protein located in the crossbridge
CC       region of vertebrate striated muscle a bands. In vitro it binds MHC, F-
CC       actin and native thin filaments, and modifies the activity of actin-
CC       activated myosin ATPase. It may modulate muscle contraction or may play
CC       a more structural role.
CC   -!- INTERACTION:
CC       O70468; P68033: Actc1; NbExp=3; IntAct=EBI-8347074, EBI-352284;
CC       O70468; Q02566: Myh6; NbExp=5; IntAct=EBI-8347074, EBI-299157;
CC       O70468; P68135: ACTA1; Xeno; NbExp=2; IntAct=EBI-8347074, EBI-367540;
CC   -!- PTM: Substrate for phosphorylation by PKA and PKC. Reversible
CC       phosphorylation appears to modulate contraction (By similarity).
CC       {ECO:0000250}.
CC   -!- PTM: Polyubiquitinated. {ECO:0000250|UniProtKB:Q14896}.
CC   -!- SIMILARITY: Belongs to the immunoglobulin superfamily. MyBP family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF059576; AAC14570.1; -; mRNA.
DR   EMBL; AF097333; AAC64202.1; -; mRNA.
DR   PDB; 4EDQ; X-ray; 1.64 A; A/B=149-269.
DR   PDBsum; 4EDQ; -.
DR   AlphaFoldDB; O70468; -.
DR   SMR; O70468; -.
DR   DIP; DIP-48624N; -.
DR   IntAct; O70468; 34.
DR   STRING; 10090.ENSMUSP00000127070; -.
DR   iPTMnet; O70468; -.
DR   PhosphoSitePlus; O70468; -.
DR   jPOST; O70468; -.
DR   MaxQB; O70468; -.
DR   PaxDb; O70468; -.
DR   PeptideAtlas; O70468; -.
DR   PRIDE; O70468; -.
DR   ProteomicsDB; 287598; -.
DR   MGI; MGI:102844; Mybpc3.
DR   eggNOG; ENOG502QWRQ; Eukaryota.
DR   InParanoid; O70468; -.
DR   Reactome; R-MMU-390522; Striated Muscle Contraction.
DR   ChiTaRS; Mybpc3; mouse.
DR   PRO; PR:O70468; -.
DR   Proteomes; UP000000589; Unplaced.
DR   RNAct; O70468; protein.
DR   GO; GO:0031672; C:A band; IDA:MGI.
DR   GO; GO:0097512; C:cardiac myofibril; ISO:MGI.
DR   GO; GO:0005856; C:cytoskeleton; TAS:MGI.
DR   GO; GO:0030016; C:myofibril; IDA:MGI.
DR   GO; GO:0030017; C:sarcomere; IDA:MGI.
DR   GO; GO:0005863; C:striated muscle myosin thick filament; ISO:MGI.
DR   GO; GO:0003779; F:actin binding; IEA:UniProtKB-KW.
DR   GO; GO:0042802; F:identical protein binding; ISO:MGI.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0017022; F:myosin binding; ISO:MGI.
DR   GO; GO:0032036; F:myosin heavy chain binding; IPI:MGI.
DR   GO; GO:0005200; F:structural constituent of cytoskeleton; TAS:MGI.
DR   GO; GO:0008307; F:structural constituent of muscle; ISO:MGI.
DR   GO; GO:0060048; P:cardiac muscle contraction; IMP:MGI.
DR   GO; GO:0007155; P:cell adhesion; IEA:UniProtKB-KW.
DR   GO; GO:0003007; P:heart morphogenesis; IMP:MGI.
DR   GO; GO:0006936; P:muscle contraction; TAS:MGI.
DR   GO; GO:0031034; P:myosin filament assembly; IMP:MGI.
DR   GO; GO:0008016; P:regulation of heart contraction; IMP:MGI.
DR   GO; GO:0002027; P:regulation of heart rate; IMP:MGI.
DR   GO; GO:0045214; P:sarcomere organization; IMP:MGI.
DR   GO; GO:0055010; P:ventricular cardiac muscle tissue morphogenesis; ISO:MGI.
DR   CDD; cd00063; FN3; 3.
DR   Gene3D; 2.60.40.10; -; 11.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR036116; FN3_sf.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR040849; MyBP-C_THB.
DR   Pfam; PF00041; fn3; 3.
DR   Pfam; PF07679; I-set; 8.
DR   Pfam; PF18362; THB; 1.
DR   SMART; SM00060; FN3; 3.
DR   SMART; SM00409; IG; 8.
DR   SMART; SM00408; IGc2; 6.
DR   SUPFAM; SSF48726; SSF48726; 8.
DR   SUPFAM; SSF49265; SSF49265; 2.
DR   PROSITE; PS50853; FN3; 3.
DR   PROSITE; PS50835; IG_LIKE; 7.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Actin-binding; Cell adhesion; Disulfide bond;
KW   Immunoglobulin domain; Metal-binding; Methylation; Muscle protein;
KW   Phosphoprotein; Reference proteome; Repeat; Thick filament;
KW   Ubl conjugation; Zinc.
FT   CHAIN           1..1270
FT                   /note="Myosin-binding protein C, cardiac-type"
FT                   /id="PRO_0000072694"
FT   DOMAIN          151..254
FT                   /note="Ig-like C2-type 1"
FT   DOMAIN          358..448
FT                   /note="Ig-like C2-type 2"
FT   DOMAIN          449..539
FT                   /note="Ig-like C2-type 3"
FT   DOMAIN          540..629
FT                   /note="Ig-like C2-type 4"
FT   DOMAIN          641..767
FT                   /note="Ig-like C2-type 5"
FT   DOMAIN          770..866
FT                   /note="Fibronectin type-III 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          868..963
FT                   /note="Fibronectin type-III 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          967..1061
FT                   /note="Ig-like C2-type 6"
FT   DOMAIN          1064..1159
FT                   /note="Fibronectin type-III 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          1177..1270
FT                   /note="Ig-like C2-type 7"
FT   REGION          1..24
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          94..152
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          683..702
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        125..141
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         206
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000250|UniProtKB:Q14896"
FT   BINDING         208
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000250|UniProtKB:Q14896"
FT   BINDING         221
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000250|UniProtKB:Q14896"
FT   BINDING         223
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000250|UniProtKB:Q14896"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0000269|PubMed:19541641"
FT   MOD_RES         47
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         72
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         273
FT                   /note="Phosphoserine; by PKA and PKC"
FT                   /evidence="ECO:0000269|PubMed:19541641"
FT   MOD_RES         282
FT                   /note="Phosphoserine; by PKA and PKC"
FT                   /evidence="ECO:0000269|PubMed:19541641"
FT   MOD_RES         302
FT                   /note="Phosphoserine; by PKA and PKC"
FT                   /evidence="ECO:0000269|PubMed:19541641"
FT   MOD_RES         307
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         423
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         455
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         546
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         603
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P56741"
FT   MOD_RES         1237
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0007744|PubMed:24129315"
FT   DISULFID        432..439
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   CONFLICT        32
FT                   /note="E -> G (in Ref. 2; AAC64202)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        39
FT                   /note="M -> K (in Ref. 2; AAC64202)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        113
FT                   /note="E -> K (in Ref. 2; AAC64202)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        249
FT                   /note="N -> S (in Ref. 2; AAC64202)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        291
FT                   /note="P -> L (in Ref. 2; AAC64202)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        339..344
FT                   /note="EACHRP -> TDLRGM (in Ref. 2; AAC64202)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        659
FT                   /note="T -> A (in Ref. 2; AAC64202)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        691
FT                   /note="A -> T (in Ref. 2; AAC64202)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        738
FT                   /note="E -> G (in Ref. 2; AAC64202)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        923
FT                   /note="R -> T (in Ref. 2; AAC64202)"
FT                   /evidence="ECO:0000305"
FT   STRAND          155..157
FT                   /evidence="ECO:0007829|PDB:4EDQ"
FT   STRAND          162..165
FT                   /evidence="ECO:0007829|PDB:4EDQ"
FT   STRAND          170..177
FT                   /evidence="ECO:0007829|PDB:4EDQ"
FT   STRAND          181..183
FT                   /evidence="ECO:0007829|PDB:4EDQ"
FT   STRAND          186..191
FT                   /evidence="ECO:0007829|PDB:4EDQ"
FT   TURN            192..194
FT                   /evidence="ECO:0007829|PDB:4EDQ"
FT   HELIX           197..200
FT                   /evidence="ECO:0007829|PDB:4EDQ"
FT   STRAND          205..212
FT                   /evidence="ECO:0007829|PDB:4EDQ"
FT   TURN            213..216
FT                   /evidence="ECO:0007829|PDB:4EDQ"
FT   STRAND          217..224
FT                   /evidence="ECO:0007829|PDB:4EDQ"
FT   HELIX           229..231
FT                   /evidence="ECO:0007829|PDB:4EDQ"
FT   STRAND          233..240
FT                   /evidence="ECO:0007829|PDB:4EDQ"
FT   STRAND          245..255
FT                   /evidence="ECO:0007829|PDB:4EDQ"
SQ   SEQUENCE   1270 AA;  140632 MW;  699947C3C9B58931 CRC64;
     MPEPGKKPVS AFNKKPRSAE VTAGSAAVFE AETERSGVMV RWQRDGSDIT ANDKYGLAAE
     GKRHTLTVRD ASPDDQGSYA VIAGSSKVKF DLKVTEPAPP EKAESEVAPG APEEVPAPAT
     ELEESVSSPE GSVSVTQDGS AAEHQGAPDD PIGLFLMRPQ DGEVTVGGSI VFSARVAGAS
     LLKPPVVKWF KGKWVDLSSK VGQHLQLHDS YDRASKVYLF ELHITDAQTT SAGGYRCEVS
     TKDKFDSCNF NLTVHEAIGS GDLDLRSAFR RTSLAGAGRR TSDSHEDAGT PDFSSLLKKR
     DSFRRDSKLE APAEEDVWEI LRQAPPSEYE RIAFQHGVEA CHRPLKRLKG MKQDEKKSTA
     FQKKLEPAYQ VNKGHKIRLT VELADPDAEV KWLKNGQEIQ MSGSKYIFES VGAKRTLTIS
     QCSLADDAAY QCVVGGEKCS TELFVKEPPV LITRSLEDQL VMVGQRVEFE CEVSEEGAQV
     KWLKDGVELT REETFKYRFK KDGRKHHLII NEATLEDAGH YAVRTSGGQS LAELIVQEKK
     LEVYQSIADL AVGAKDQAVF KCEVSDENVR GVWLKNGKEL VPDNRIKVSH IGRVHKLTID
     DVTPADEADY SFVPEGFACN LSAKLHFMEV KIDFVPRQEP PKIHLDCPGS TPDTIVVVTG
     NKLRLDVPIS GDPAPTVVWQ KTVTQGKKAS AGPHPDAPED AGADEEWVFD KKLLCETEGR
     VRVETTKDRS VFTVEGAEKE DEGVYTVTVK NPVGEDQVNL TVKVIDVPDA PAAPKISNVG
     EDSCTVQWEP PAYDGGQPVL GYILERKKKK SYRWMRLNFD LLRELSHEAR RMIEGVAYEM
     RVYAVNAVGM SRPSPASQPF MPIGPPGEPT HLAVEDVSDT TVSLKWRPPE RVGAGGLDGY
     SVEYCQEGCS EWTPALQGLT ERRSMLVKDL PTGARLLFRV RAHNVAGPGG PIVTKEPVTV
     QEILQRPRLQ LPRHLRQTIQ KKVGEPVNLL IPFQGKPRPQ VTWTKEGQPL AGEEVSIRNS
     PTDTILFIRA ARRTHSGTYQ VTVRIENMED KATLILQIVD KPSPPQDIRI VETWGFNVAL
     EWKPPQDDGN TEIWGYTVQK ADKKTMEWFT VLEHYRRTHC VVSELIIGNG YYFRVFSHNM
     VGSSDKAAAT KEPVFIPRPG ITYEPPKYKA LDFSEAPSFT QPLANRSIIA GYNAILCCAV
     RGSPKPKISW FKNGLDLGED ARFRMFCKQG VLTLEIRKPC PYDGGVYVCR ATNLQGEAQC
     ECRLEVRVPQ
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024